Recombinant Antigen
Recombinant antigens are synthetically produced proteins generated through recombinant DNA technology, where a gene encoding the desired antigen is cloned and expressed in a host system such as bacteria, yeast, insect, or mammalian cells. These antigens are designed to mimic the structure and function of native antigens, enabling their use in diagnostics, vaccine development, and immunological research. The recombinant approach offers advantages in purity, scalability, and reproducibility over traditionally extracted antigens.
Technical Content
- Production Methodology:
- The gene coding for the antigen is inserted into an expression vector and introduced into a host organism.
- Protein purification employs affinity tags (e.g., His-tag, GST-tag) and techniques like size-exclusion or ion-exchange chromatography.
- Key Features:
- High Purity and Yield: Recombinant production ensures antigens are free of contaminants and impurities typically associated with extraction from natural sources.
- Epitope Preservation: Retains immunologically relevant conformational or linear epitopes critical for antibody binding or T-cell activation.
- Verification and Characterization:
- Structural Analysis: Verified using X-ray crystallography or circular dichroism (CD).
- Functional Validation: Ensured through assays such as ELISA, Western blot, and surface plasmon resonance (SPR).
- Purity Testing: Conducted using SDS-PAGE and mass spectrometry.
Applications
- Vaccine Development:
- Subunit Vaccines: Recombinant antigens are central components in subunit vaccines, as demonstrated in vaccines for SARS-CoV-2, Hepatitis B, and Human Papillomavirus (HPV).
- Antigenicity Testing: Enables the identification of epitopes critical for protective immunity.
- Diagnostics:
- Recombinant antigens are widely used in serological assays such as ELISA, lateral flow tests, and immunofluorescence assays to detect pathogen-specific antibodies.
- Examples include detection kits for HIV, Influenza, and Dengue virus.
- Therapeutic Antibody Development:
- Serve as targets in the development of monoclonal antibodies for infectious and autoimmune diseases.
- Research Applications:
- Facilitate studies in immunology and pathogenesis by providing reliable tools to analyze host-pathogen interactions, antibody binding, and antigen processing.
Recombinant antigens are revolutionizing the fields of diagnostics and vaccinology, providing a robust, reliable, and scalable solution for addressing global healthcare challenges.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|